Live Breaking News & Updates on Fabien Sebille

Stay updated with breaking news from Fabien sebille. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Purple Biotech Appoints Dr. Yael Margolin to its Board of Directors

Dr. Margolin brings 35 years of expertise in biotechnology, pharma, and venture capital Purple Biotech also announces the resignation of Mr. Fabien Sebille, who served as the Company’s Chief. ....

Lior Fhima , Gil Efron , Yael Margolin , Company Contact , Tel Aviv University , Gamida Cell Ltd , Company Board Of Directors , Drug Administration , Exchange Commission , Denali Ventures , Purple Biotech Ltd , Bristol Myers Squibb , Weitzman Institute Of Science , Ramot At Tel Aviv University , Yale University School Of Medicine , Teva Pharmaceuticals , Fabien Sebille , Chief Business , Point Biopharma Global , Welltech Ventures , Tel Aviv , Chief Executive Officer , Gamida Cell , Vice President , Cum Laude , Weitzman Institute ,

Netris Pharma Raises €7.5M; Extends Series A to €24.4M

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time! ....

Patrick Mehlen , Netris Pharma , Chief Executive Officer , Fabien Sebille , Chief Business Officer ,

Purple Biotech Issues Letter to Shareholders

Press release content from Globe Newswire. The AP news staff was not involved in its creation. ....

United States , Gil Efron , Robert Gagnon , Bristol Myers Squibb , Suzana Nahum Zilberberg , Exchange Commission , Department Of Cancer Biology , University Of Texas Md Anderson Cancer Center , Company Contact , Purple Biotech Ltd , Drug Administration , Purple Biotech , Chief Executive Officer , Isaac Israel , Cancer Center , Menashe Bar Eli , Cancer Biology , Ori Hershkovitz , Fabien Sebille , Chief Business , Looking Statements , Safe Harbor , Private Securities Litigation Reform Act , Annual Report , Registration Statements , Middle East ,

Purple Biotech Issues Letter to Shareholders

REHOVOT, Israel, Feb. 04, 2022 (GLOBE NEWSWIRE) Purple Biotech Ltd. ("Purple Biotech", or the "Company") (NASDAQ/TASE: PPBT), a clinical-stage company developing first-in-class, effective and durable therapies by overcoming tumor ....

United States , Gil Efron , Robert Gagnon , Bristol Myers Squibb , Suzana Nahum Zilberberg , Exchange Commission , Department Of Cancer Biology , University Of Texas Md Anderson Cancer Center , Company Contact , Purple Biotech Ltd , Drug Administration , Purple Biotech , Chief Executive Officer , Isaac Israel , Cancer Center , Menashe Bar Eli , Cancer Biology , Ori Hershkovitz , Fabien Sebille , Chief Business , Chief Executive Officer Purple , Looking Statements , Safe Harbor , Private Securities Litigation Reform Act , Annual Report , Registration Statements ,

Purple Biotech Appoints Senior Business Development

REHOVOT, Israel, Dec. 09, 2021 (GLOBE NEWSWIRE) Purple Biotech Ltd. ("Purple Biotech", or the "Company") (NASDAQ/TASE: PPBT), a clinical-stage. ....

City Of , United Kingdom , Immunotherapeutics Euronext , Gil Efron , University Of Nantes , Purple Biotech Ltd , Debiopharm International , Imperial College , Bristol Myers Squibb , Business Development , Fabien Sebille , Chief Business , Executive Director , Alsace Biovalley , Tcland Expression , Technology Transfer Officer , Technology Transfer Office , Medical Research , Chief Business Officer , Purple Biotech , Chief Financial , Nasdaq Ppbt , Purple Biotech Ltd ,